BrightInsight is a digital health platform that powers digital health transformation for life sciences companies, delivering scalable, compliant, cloud-based solutions to revolutionize patient outcomes.

BrightInsight

Joint Medical Company provides a comprehensive catalog of medical products and services across the spectrum, from injection syringes to advanced diagnostic instruments and hospital equipment. The company aims to improve medical outcomes and preserve health.

Joint Medical Company

Savor Health provides nutrition solutions for individuals and enterprises, focusing on the dietary needs of cancer patients.

Savor Health

Humanis specializes in consumer health products, focusing on integrating quality into health solutions, self-described as a reliable partner for global pharmaceutical companies.

Humanis

BrightInsight provides the leading global platform for biopharma and medtech regulated digital health solutions. 

We are the launch partner companies trust to accelerate time to market for regulated digital health products including apps, algorithms, medical devices, connected combination products, companion diagnostics, and Software as a Medical Device (SaMD). 

BrightInsight replaces the need for lengthy and complex ‘build from scratch’ implementations. Instead, we offer a proven platform and configurable software modules, built to meet the most stringent global security, privacy, and regulatory requirements. We can also serve as the Legal Manufacturer of Record for your digital health products. 

When building your digital health solutions on the BrightInsight®️ Platform, you are future-proofing compliance while ensuring scalability across geographies.

New Leaf Venture Partners

Eclipse Ventures

Insight Partners

Gaingels

General Catalyst

Sand Hill Angels

Red Hook Capital

It’s more than a New Year’s resolution. It’s a whole new BrightInsight. We’re kicking off 2024 with a brand-new look and feel that shines brighter—showcasing our position as the trusted partner and de facto platform for digital health. 🎉🏆🤩

✨ See more at https://brightinsight.com/

This year was one of contraction in the #digitalhealth space, starting with a “new normal” investment climate. Given the current landscape, pharmaceutical and medical device companies are right to be chary of potential digital health partners. 

In this new Forbes article, Kal Patel, M.D., MBA discusses how pharmaceutical and medical device companies can distinguish high-quality companies. Learn more: https://lnkd.in/gaueBD8k

At #JPM2024, we asked entrepreneurs, biopharma executives, and thought leaders on their top 2024 predictions! 🧠🎤 Here's what they told us.

A big thank you to Emmanuel Frenehard (Sanofi), Justin Butler (Eclipse Ventures), Amar Goel (Bito), Kal Patel, M.D., MBA (BrightInsight), Stephen R. (Roche), Donald Jones (Takeda), and Ashish Agrawal (BrightInsight) for sharing your thoughts with us!

Also check out this new #JPM blog from Kal Patel, M.D., MBA: JPM Healthcare Conference: Is Generative AI Ready for Life Sciences? https://lnkd.in/gW57hSeP

Ready to start your digital transformation but worried about how long it will take to have a measurable impact on your clinical and business goals? That’s where we come in. 💡🏆✨

In our new eBook, we’re outlining the many reasons working with a proven technology partner is the best way to accelerate speed to value. Read our eBook to learn more: https://lnkd.in/gKTtBFgt

Kicked off the new year with a bang at #JPM2024 in San Francisco! 💥🎉 Jamie Eisinger Burgess, Kal Patel, M.D., MBA, and Ashish Agrawal rang the closing bell with Nasdaq and the other Deloitte Technology #Fast500 winners! 

The Deloitte Technology Fast 500 list is comprised of the fastest-growing technology, life sciences, media, telecommunications, fintech and energy tech companies - both public and private - in North America. 🚀🌎

We are honored to be ranked 307th on the list and to have joined the other companies on the Nasdaq tower! 🤝

#digitalhealth #brightinsight #nasdaq #jpm23

…ready for it? 🚨

 January 8th, 2024 👀

Something BIG is coming 🤔✨

As this year comes to a close, we want to thank you for being part of the BrightInsight community. Happy Holidays and Happy New Years! - from your friends at BrightInsight 🎄❄️🌟

That’s a wrap on 2023! 🥳 This year, BrightInsight entered our #LaunchEra, helping our customers drive revenue, improve patient outcomes and build brand loyalty through new product launches and global expansion. 🚀🏆🌎

We’re excited for what 2024 holds for BrightInsight, our team members, our customers, and the #digitalhealth industry as a whole. Check out our 2023 Wrapped video to see our top highlights for the year! 🎉

We are excited to announce major milestones for CSL Behring’s Hizentra app, which supports patients taking #Hizentra with medication reminders, record management, infusion tracking and more! 📣

The latest version of the app introduces exciting new capabilities and an updated design. The update also expands the app’s footprint geographically, reaching new markets in Latin America and Canada, in addition to the existing regions of the U.S. and Japan. 🌎 Learn more in our new blog: https://bit.ly/3RnWfEc

In recent conversations, a common theme has emerged: Frontline marketing teams are limited in their thinking around digital health strategy. But in the C-suite, the thinking is that digital is an ideal way to cut through the noise and deliver much more impact on the patient experience and the bottom line.

In this new Forbes article, Kal Patel, M.D., MBA shares some steps on how pharma marketing teams can think bigger about digital: https://lnkd.in/gFHGDeH6

Metric
Company Name	BrightInsight	Joint Medical Company	Savor Health	Humanis
Symbol
MSH ID	COM:BRIGHTINSIGHT	COM:JOINTMEDICALKW	COM:SAVORHEALTH	LIFE:HUMANIS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Medical Equipment and Supplies	Health and Wellness	Pharmaceuticals
Country	US	KW	US	TR
Stage
Employee Count	210
Website	brightinsight.com	jointmedicalkw.com	savorhealth.com	humanis.life
LinkedIn	brightinsight-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			1.36K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BRIGHTINSIGHT

BrightInsight

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue